Avid Bioservices Inc (CDMO)

[entdoc]

by-the-way, thanks as usual to CJGaddy for the data base he provides us with here which enables us to determine that PPHM just showed a 55% gain in over-all response rate when adding Bavi to standard of care chemo(toxins) used for fighting advanced, metastatic lung cancer. In my mind there is no question about Bavi having cancercidal effects. Now we simply must find the right application...and that is early application. These trials are (believe it or not) enabling us to move in that direction. Safety is the key. It seems at this point that we have that key.